US. 15/952,203
`Response to Sequence Listing Notice filed July 10, 2018
`
`AMENDMENTS TO THE SPECIFICATION
`
`Please amend the specification as shown:
`
`Please insert the following on page 1, after the priority paragraph:
`
`SEQUENCE LISTING
`
`[0001.1]
`
`The instant application contains a Sequence Listing which has been filed
`
`electronically in ASCII format and is hereby incorporated by reference in its entirety. Said
`
`ASCII copy, created on July 10, 2018, is named 47697_709_20l_SL.txt and is 2,751 bytes in
`
`size.
`
`Please delete paragraph [00329] and replace it with the following paragraph:
`
`[00329]
`
`Ligation of the first adapter. PEG-4000 (32 uL, 50%), single-stranded adapter
`
`oligo CL78 (l uL, 10 pM, 5’-[Phosphate]AGATCGGAAG[C3 Spacer] 10[TEG—biotin]-3’, (TEG
`
`= triethylene glycol spacer) [SEQ ID NO: 4]), and CircLigase II (4 uL, 100 U uL'l) were added
`
`to the reaction mixtures to obtain a final reaction volume of 80 [LL The contents of the tubes
`
`were mixed before adding CircLigase II. The tubes were spun briefly in a microcentrifuge. The
`
`reaction mixtures were incubated in a thermal cycler with a heated lid for 1 hr at 60 oC. Stop
`
`solution (2 uL) (98 [LL of 0.5 M EDTA (pH 8.0) and 2 [LL of Tween 20 were combined to make
`
`100 uL of stop solution) was added to each reaction mixture. The contents were mixed, and the
`
`tubes were spun in a microcentrifuge.
`
`Please delete paragraph [00332] and replace it with the following paragraph:
`
`[00332]
`
`Bst 2.0 polymerase. For the master mix comprising, Bst 2.0 polymerase, 40.5 uL
`
`water, 5 [LL 10>< isothermal amplification buffer (New England Biolabs), 0.5 uL dNTP mix (25
`
`mM each), and 1 [LL extension primer CL9 (5’-
`
`GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-3’ [SEQ ID NO: 1], 100 uM) were
`
`combined to make 47 [LL master mix. The beads were pelleted using a magnetic rack, and the
`
`wash buffer was discarded. The 47-uL reaction mixture was added to the pelleted beads, and the
`
`beads were resuspended by vortexing. The tubes were incubated in a thermal shaker for 2 min at
`
`1007 3345_1.doc
`
`-2-
`
`Attorney Docket No. 47697-709201
`
`

`

`US. 15/952,203
`Response to Sequence Listing Notice filed July 10, 2018
`
`65 oC. The tubes were placed in an ice-water bath for l min and then were immediately
`
`transferred to a thermal cycler precooled to 15 oC. While the tubes were placed on the thermal
`
`cycler, a polymerase (e.g., Bst 2.0 polymerase (3 uL, 24 U, New England Biolabs), DNA
`
`polymerase, or reverse transcriptase) was added to each reaction mixture. The tubes were mixed
`
`briefly by vortexing and returned to the thermal cycler. The reaction mixtures were incubated by
`
`increasing the temperature by l 0C per minute, ramping the temperature up from 15 0C to 37 oC.
`
`The reaction mixtures were incubated for 5 min at 37 oC. The tubes were spun briefly in a
`
`microcentrifuge. The beads were pelleted using a magnetic rack, and the supernatant was
`
`discarded.
`
`Please delete paragraph [00334] and replace it with the following paragraph:
`
`[00334]
`
`SMARTer RT. Clonetech SMARTer RT can be used in place of Bst 2.0
`
`polymerase, according to the manufacturer’s instructions with the following modifications: 1) in-
`
`house extension primer CL9 (5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-3’
`
`[SEQ ID NO:1[) was used for the primer extension in step 4 of the protocol in place of the
`
`manufacturer’s 3’ SMART CDS Primer II A, and 2) SMART-Seq V4 oligonucleotide was not
`
`used in the Step 6 of the manufacturer’s protocol. The beads were pelleted on the magnet and
`
`reverse transcription products were collected in the supernatant, purified, amplified by PCR, and
`
`sequenced. Results were quantified also using TapeStation (Agilent).
`
`Please delete paragraph [00337] and replace it with the following paragraph:
`
`[00337]
`
`Ligation of second adapter and library elution. A master mix was prepared for
`
`the required number of reactions (98 [LL per reaction). 73.5 uL water, 10 [LL 10>< T4 DNA ligase
`
`buffer, 10 [LL PEG-4000 (50%), 2.5 uL Tween 20 (1%), and 2 [LL double-stranded adapter (100
`
`uM) were combined to make 98 [LL master mix. To make the double-stranded adapter stock
`
`solution, 9.5 uL of TE buffer, 0.5 pL of 5 M NaCl, 20 [LL of 500 uM oligonucleotide CL53 (5’-
`
`CGACGCTCTTC-ddC [SEQ ID NO: 2]) (ddC = dideoxycytidine), and 20 pL of 500 uM
`
`oligonucleotide CL73 (5’-[Phosphate]GGAAGAGCGTCGTGTAGGGAAAGAG*T*G*T*A-3’
`
`[SEQ ID NO: 3]) (* = phosphothioate linkage) were combined in a PCR tube, the reaction
`
`mixture was incubated in a thermal cycler for 10 s at 95 0C, the temperature was slowly
`
`decreased at the rate of 0.1 0C per second until reaching 14 oC, and 50 [LL of TE buffer was
`
`10073345_1.doc
`
`-3-
`
`Attorney Docket No. 47697-709201
`
`

`

`US. 15/952,203
`Response to Sequence Listing Notice filed July 10, 2018
`
`added to the hybridized adapter to obtain a concentration of 100 uM in a total volume of 100 uL.
`
`49.4 mL of water, 500 uL of l M Tris-HCl (pH 8.0), and 100 uL of 0.5 M EDTA (pH 8.0) were
`
`combined to make 50 mL of TE buffer. The beads were pelleted using a magnetic rack, and the
`
`wash buffer was discarded. The reaction mixture (98 uL) was added to the pelleted beads, and
`
`the beads were resuspended by vortexing. T4 DNA ligase (2 uL, 10 U, Thermo Scientific) was
`
`added. The contents were mixed briefly by vortexing. The reaction mixtures were incubated for 1
`
`hr at room temperature. The beads were kept suspended during incubation. The beads were
`
`pelleted using a magnetic rack, and the supernatant was discarded. The beads were washed once
`
`with 200 pl of wash buffer A. The beads were resuspended in 100 uL of stringency wash buffer,
`
`and the bead suspensions were incubated for 3 min at 45 0C in a thermal shaker. The beads were
`
`pelleted using a magnetic rack, and the supernatant was discarded. The beads were washed once
`
`with 200 uL of wash buffer B. The beads were pelleted using a magnetic rack, and the
`
`supernatant was discarded. TET buffer (25 uL) (49.375 mL of water, 500 uL of l M Tris-HCl,
`
`100 uL of 0.5 M EDTA, and 25 [LL of Tween 20 were combined to make 50 mL of TET buffer)
`
`was added to the pelleted beads, and the beads were resuspended by vortexing. The bead
`
`suspension was transfer to 0.2-mL PCR strip tubes. The tubes were spun briefly in a
`
`microcentrifuge. The bead suspensions were incubated for l min at 95 0C in a thermal cycler
`
`with a heated lid. The PCR strip tubes were immediately transferred to a 96-well magnetic rack.
`
`The supernatant was transferred, which contains the library molecules, to a fresh 0.5-mL tube.
`
`Please delete paragraph [00339] and replace it with the following paragraph:
`
`[00339]
`
`Sequencing. For sequencing, the protocols and instructions for multiplex
`
`sequencing provided by Illumina were followed. The sequencing primer of the first read was
`
`replaced by the custom primer CL72 (5’-ACACTCTTTCCCTACACGACGCTCTTCC-3’m
`
`ID NO: 16]). A ready-to-use dilution of CL72 was freshly prepared before sequencing by
`
`mixing 10 [LL from the 100 uM stock solution with 1,990 uL of hybridization buffer (provided
`
`with the sequencing reagents).
`
`Please delete paragraph [00346] and replace it with the following paragraph:
`
`[00346]
`
`The adapter used in the CircLigase II and T4 RNA Ligase 1 ligation: The
`
`adapter used was
`
`1007 3345_1.doc
`
`-4-
`
`Attorney Docket No. 47697-709201
`
`

`

`US. 15/952,203
`Response to Sequence Listing Notice filed July 10, 2018
`
`/5Phos/AGATCGGAAG/iSpC3/iSpC3/iSpC3/iSpC3/iSpC3/iSpC3/iSpC3/iSpC3/iSpC3/iSpC3/3
`
`BioTEG/ (SEQ ID NO: 41 and contains 5’-phosphy1ation, 3’-biotiny1ation, and non-nucleotide
`
`polymer extension. The Thermostable App ligase requires an App modification (eg, pre-
`
`adenylation) at the 5’-end.
`
`Please delete paragraph [00350] and replace it with the following paragraph:
`
`[00350]
`
`Post-ligation reverse transcription was performed with Clonetech SMARTer
`
`E: The reverse transcription reaction was carried out according to the manufacturer’s
`
`instructions with the following modifications: 1) in-house extension primer CL9 (5’-
`
`GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-3’ (SEQ ID NO: 1 1) was used for the
`
`primer extension reaction in step 4 of the protocol in place of the manufacturer’s 3’ SMART
`
`CDS Primer II A, and 2) SMART-Seq V4 oligonucleotide was not used in the step 6 of the
`
`manufacturer’s protocol. Reverse transcription products were amplified by PCR. The amplified
`
`products were quantified using TapeStation (Agilent).
`
`10073345_1.doc
`
`-5-
`
`Attorney Docket No. 47697-709201
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.